Search

eNews Sign-Up!

Edit Profile  
Sign-up to receive our quarterly e-newsletter full of healthy advice.
*
*
*

Hospital Research & Clinical Trials

  • Contact Us
  • News Awards and Presentations

    News:

    December 2010: "Summa Researchers Explore Apatone’s Potential to Fight Cancer and Other Diseases." Summa Magazine.

    Spring of 2012: "Innovative Anticancer Drugs and Strategies." 2nd International Symposium (IADS-2). Akron, Ohio. 

    James Jamison: Co-Organizer of The Innovative Anticancer Drugs and Strategies 1st International Symposium (IADS-1). June 2-4, 2010. Newcastle, England.

    Awards:

    Apatone Development Center awarded one of the Initial Collaborative Research & Development Grants from The Austen BioInnovation Institute in Akron, 2010

    J.M. Jamison, Summa Health System; Y.H. Yun, The University of Akron; V.E. von Gruenigen, Summa Health System; and C-c. Tsai, Kent State University. “Development of Delivery Mechanisms for Liquid Crystalline Pharmaceuticals Using Electrospinning.” 

    Presentations

    Karen McGuire

    “Nucleolar changes and fibrillarin redistribution following Apatone® treatment of human bladder and prostate carcinoma cells.” Innovative Anticancer Drugs and Strategies 1st International Symposium (IADS-1). June 2-4, 2010. Newcastle, England.

    “Elucidating the Pathway of Apatone® Induced DNase II Reactivation During Autoschizic Cell Death.” MSA Meeting. July 29, 2009. Richmond, VA. MSA Presidential Award.

    Debbie Neal

    “Apatone® Exhibits Antitumor Activity Against Prostate Cancer.” Innovative Anticancer Drugs and Strategies 1st International Symposium (IADS-1). June 2-4, 2010. Newcastle, England.

    “Apatone® Treatment Inhibits the Inflammatory Response in Human Synovial Fibroblasts Following Metal Particulate Exposure by Reducing NF-kB Levels.” MSA Meeting. July 29, 2009. Richmond, VA. 

    • Summa Health System © 2014 | All Rights Reserved | 525 East Market Street, Akron, Ohio 44304 | (888) 905-6071